vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and NNN REIT, INC. (NNN). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $240.4M, roughly 1.1× NNN REIT, INC.). NNN REIT, INC. runs the higher net margin — 39.1% vs 0.7%, a 38.4% gap on every dollar of revenue. On growth, NNN REIT, INC. posted the faster year-over-year revenue change (4.1% vs -16.5%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
NNN Reit, Inc. is a real estate investment trust that invests primarily in restaurant properties that are subject to long-term triple net leases, usually under leaseback arrangements. It is organized in Maryland with its principal office in Orlando, Florida.
HCM vs NNN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $240.4M |
| Net Profit | $2.0M | $94.0M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 61.0% |
| Net Margin | 0.7% | 39.1% |
| Revenue YoY | -16.5% | 4.1% |
| Net Profit YoY | -83.6% | -2.6% |
| EPS (diluted) | $0.00 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $240.4M | ||
| Q4 25 | $270.8M | $238.4M | ||
| Q3 25 | — | $230.2M | ||
| Q2 25 | $277.7M | $226.8M | ||
| Q1 25 | $324.5M | $230.9M | ||
| Q4 24 | — | $218.5M | ||
| Q3 24 | — | $218.6M | ||
| Q2 24 | $305.7M | $216.8M |
| Q1 26 | — | $94.0M | ||
| Q4 25 | $2.0M | $96.0M | ||
| Q3 25 | — | $96.8M | ||
| Q2 25 | $455.0M | $100.5M | ||
| Q1 25 | $11.9M | $96.5M | ||
| Q4 24 | — | $97.9M | ||
| Q3 24 | — | $97.9M | ||
| Q2 24 | $25.8M | $106.7M |
| Q1 26 | — | — | ||
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — |
| Q1 26 | — | 61.0% | ||
| Q4 25 | -13.2% | 62.3% | ||
| Q3 25 | — | 64.0% | ||
| Q2 25 | -1.3% | 66.0% | ||
| Q1 25 | -5.0% | 62.3% | ||
| Q4 24 | — | 65.8% | ||
| Q3 24 | — | 65.7% | ||
| Q2 24 | -9.0% | 70.2% |
| Q1 26 | — | 39.1% | ||
| Q4 25 | 0.7% | 40.2% | ||
| Q3 25 | — | 42.1% | ||
| Q2 25 | 163.8% | 44.3% | ||
| Q1 25 | 3.7% | 41.8% | ||
| Q4 24 | — | 44.8% | ||
| Q3 24 | — | 44.8% | ||
| Q2 24 | 8.4% | 49.2% |
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.00 | $0.51 | ||
| Q3 25 | — | $0.51 | ||
| Q2 25 | $0.52 | $0.54 | ||
| Q1 25 | $0.01 | $0.51 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | — | $0.53 | ||
| Q2 24 | $0.03 | $0.58 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $4.6M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $4.4B |
| Total Assets | $1.8B | $9.4B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $4.6M | ||
| Q4 25 | $1.4B | $5.0M | ||
| Q3 25 | — | $157.9M | ||
| Q2 25 | $1.4B | $6.0M | ||
| Q1 25 | $836.1M | $5.1M | ||
| Q4 24 | — | $8.7M | ||
| Q3 24 | — | $173.5M | ||
| Q2 24 | $802.5M | $2.1M |
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — |
| Q1 26 | — | $4.4B | ||
| Q4 25 | $1.2B | $4.4B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | $1.2B | $4.4B | ||
| Q1 25 | $759.9M | $4.4B | ||
| Q4 24 | — | $4.4B | ||
| Q3 24 | — | $4.4B | ||
| Q2 24 | $740.1M | $4.2B |
| Q1 26 | — | $9.4B | ||
| Q4 25 | $1.8B | $9.4B | ||
| Q3 25 | — | $9.5B | ||
| Q2 25 | $1.8B | $9.1B | ||
| Q1 25 | $1.3B | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.9B | ||
| Q2 24 | $1.3B | $8.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $667.1M | ||
| Q3 25 | — | $218.3M | ||
| Q2 25 | $-72.9M | $119.4M | ||
| Q1 25 | $40.3M | $203.3M | ||
| Q4 24 | — | $635.5M | ||
| Q3 24 | — | $206.6M | ||
| Q2 24 | $-39.8M | $120.5M |
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-49.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -16.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.21× | 6.95× | ||
| Q3 25 | — | 2.25× | ||
| Q2 25 | -0.16× | 1.19× | ||
| Q1 25 | 3.38× | 2.11× | ||
| Q4 24 | — | 6.49× | ||
| Q3 24 | — | 2.11× | ||
| Q2 24 | -1.54× | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
